J Volmink, P Garner. Show Affiliations »
Abstract
Mesh: See more » Antitubercular Agents/therapeutic useCost-Benefit AnalysisDrug Therapy/economicsDrug Therapy/standardsHumansPatient ComplianceTuberculosis/drug therapyUnited Nations
Substances: See more » Antitubercular Agents
Year: 1997 PMID: 9149729 DOI: 10.1016/s0140-6736(05)63244-8
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321